Yuvraj_pawp, Author at Pharma Advancement

GAINESVILLE, Fla. — At the conclusion of the first year of UF Health’s Personalized Medicine Program, the results are in:...

European Commission grants marketing approval for Teva’s DuoResp Spiromax

by Yuvraj_pawp

30th April 2014

Teva Pharmaceutical has obtained marketing authorisation approval from European Commission for its DuoResp Spiromax for treatment of patients with asthma...

Janssen’s type 2 diabetes drug Vokanamet gets European Commission approval in EU

by Yuvraj_pawp

29th April 2014

Janssen-Cilag International (Janssen) has received approval from the European Commission (EC) for use of Vokanamet in the European Union (EU)...

Bavarian Nordic doses first patient in Phase II trial of CV-301 to treat bladder cancer

by Yuvraj_pawp

29th April 2014

Denmark-based biotechnology firm Bavarian Nordic has dosed first patient in a randomised, prospective Phase II trial of its active immunotherapy...

Alexion begins multinational registration trials of eculizumab to treat NMO and MG

by Yuvraj_pawp

28th April 2014

US-based Alexion Pharmaceuticals has started a single, multinational, placebo-controlled trial designed to assess the safety and efficacy of eculizumab (Soliris)...

NICE recommends afatinib for treatment of lung cancer

by Yuvraj_pawp

28th April 2014

The National Institute for Health and Care Excellence (NICE) in the UK has issued its final health technology appraisal recommending...

Pfizer confirms £60bn bid interest in AstraZeneca

by Yuvraj_pawp

28th April 2014

US-based drug maker Pfizer has confirmed that it has contacted AstraZeneca seeking to renew discussions over a possible £60bn takeover....

Eli Lilly’s Cyramza becomes first FDA-approved gastric cancer drug

by Yuvraj_pawp

24th April 2014

Eli Lilly has obtained US Food and Drug Administration approval for its Cyramza (ramucirumab) as a single-agent treatment for patients...

Abbvie starts Phase III trial of lung cancer drug veliparib

by Yuvraj_pawp

17th April 2014

US-based biopharmaceutical firm AbbVie has started a global Phase III clinical trial of an investigational oral poly (adenosine diphosphate -ribose)...

Victoria Falls International Airport, Zimbabwe

by Yuvraj_pawp

27th March 2014

Victoria Falls International Airport (VFIA) is one of the main airports in Zimbabwe. The airport is located 18km away from...

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Advanced Instruments All Set To Merge With Nova Biomedical

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

Continuous Bioprocessing Market to Surge by 2028

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Advanced Instruments All Set To Merge With Nova Biomedical

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

Continuous Bioprocessing Market to Surge by 2028

Yuvraj_pawp

UF Health successfully implements genomic medicine program

European Commission grants marketing approval for Teva’s DuoResp Spiromax

Janssen’s type 2 diabetes drug Vokanamet gets European Commission approval in EU

Bavarian Nordic doses first patient in Phase II trial of CV-301 to treat bladder cancer

Alexion begins multinational registration trials of eculizumab to treat NMO and MG

NICE recommends afatinib for treatment of lung cancer

Pfizer confirms £60bn bid interest in AstraZeneca

Eli Lilly’s Cyramza becomes first FDA-approved gastric cancer drug

Abbvie starts Phase III trial of lung cancer drug veliparib

Victoria Falls International Airport, Zimbabwe

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password